FrederickBarrettMD
Pediatric Infectious Disease • Memphis, TNInstructor of Psychiatry and Behavioral Sciences
Are you Dr. Barrett?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 6 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1910 Nonconnah Blvd
Suite 120
Memphis, TN 38132Phone+1 901-448-2300Fax+1 901-448-6657
Summary
- Dr. Frederick Barrett, MD is a pediatric infectious disease specialist in Memphis, Tennessee.
Education & Training
Boston Children’s Hospital/Boston Medical Center AFellowship, Pediatric Infectious Diseases, 1966 - 1968
Baylor College of Medicine (Houston)Residency, Pediatrics, 1964 - 1965- Baylor College of MedicineClass of 1961
Certifications & Licensure
- American Board of Pediatrics Pediatrics
Clinical Trials
- Persisting Effects of Psilocybin Start of enrollment: 2017 Jul 01
- Effects of Salvinorin A on Brain Function Start of enrollment: 2017 Dec 14
Publications & Presentations
PubMed
- 55 citationsDouble-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognitionFrederick S. Barrett, Theresa M. Carbonaro, Ethan Hurwitz, Matthew W. Johnson, Roland R. Griffiths
Psychopharmacology. 2018-07-30 - 59 citationsAn outbreak of aspergillosis in children with acute leukemiaDonald H. Mahoney, C. Philip Steuber, Kenneth A. Starling, Fred F. Barrett, Jacobo Goldberg
The Journal of Pediatrics. 1979-07-01 - 34 citationsKlebsiella-Enterobacter at Boston City Hospital, 1967Peter E. Dans, Fred F. Barrett, John I. Casey, Maxwell Finland
Archives of Internal Medicine. 1970-01-01
Press Mentions
- How Psilocybin, the Psychedelic in Mushrooms, May Rewire the Brain to Ease Depression, Anxiety and MoreJune 11th, 2022
- PharmaDrug Announces Clinical Research Collaboration with Johns Hopkins University to Evaluate DMT in a Comparative Clinical StudyAugust 25th, 2021
- PharmaDrug Announces Clinical Research Collaboration with the Johns Hopkins University to Evaluate DMT in a Comparative Clinical StudyAugust 25th, 2021
- Join now to see all
